929 related articles for article (PubMed ID: 12496748)
21. Use of intravenous infusion sedation among mechanically ventilated patients in the United States.
Wunsch H; Kahn JM; Kramer AA; Rubenfeld GD
Crit Care Med; 2009 Dec; 37(12):3031-9. PubMed ID: 19633543
[TBL] [Abstract][Full Text] [Related]
22. A phase II study to evaluate the efficacy of dexmedetomidine for sedation in the medical intensive care unit.
Venn M; Newman J; Grounds M
Intensive Care Med; 2003 Feb; 29(2):201-7. PubMed ID: 12594584
[TBL] [Abstract][Full Text] [Related]
23. The effect of age on the pharmacokinetics and pharmacodynamics of midazolam.
Albrecht S; Ihmsen H; Hering W; Geisslinger G; Dingemanse J; Schwilden H; Schüttler J
Clin Pharmacol Ther; 1999 Jun; 65(6):630-9. PubMed ID: 10391668
[TBL] [Abstract][Full Text] [Related]
24. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part II. Population pharmacokinetic and pharmacodynamic modeling and simulation.
Wiltshire HR; Kilpatrick GJ; Tilbrook GS; Borkett KM
Anesth Analg; 2012 Aug; 115(2):284-96. PubMed ID: 22253270
[TBL] [Abstract][Full Text] [Related]
25. The effects of obstructive jaundice on the pharmacodynamics of propofol: does the sensitivity of intravenous anesthetics change among icteric patients?
Song JC; Zhang MZ; Lu ZJ; Yang LQ; Song JG; Sun YM; Yu WF
Acta Anaesthesiol Scand; 2009 Nov; 53(10):1329-35. PubMed ID: 19681778
[TBL] [Abstract][Full Text] [Related]
26. Population pharmacokinetics of raltitrexed in patients with advanced solid tumours.
Blair EY; Rivory LP; Clarke SJ; McLachlan AJ
Br J Clin Pharmacol; 2004 Apr; 57(4):416-26. PubMed ID: 15025739
[TBL] [Abstract][Full Text] [Related]
27. Population pharmacodynamic modelling of lorazepam- and midazolam-induced sedation upon long-term continuous infusion in critically ill patients.
Swart EL; Zuideveld KP; de Jongh J; Danhof M; Thijs LG; Strack van Schijndel RM
Eur J Clin Pharmacol; 2006 Mar; 62(3):185-94. PubMed ID: 16425056
[TBL] [Abstract][Full Text] [Related]
28. The pharmacokinetics of propofol in ICU patients undergoing long-term sedation.
Smuszkiewicz P; Wiczling P; Przybyłowski K; Borsuk A; Trojanowska I; Paterska M; Matysiak J; Kokot Z; Grześkowiak E; Bienert A
Biopharm Drug Dispos; 2016 Nov; 37(8):456-466. PubMed ID: 27556962
[TBL] [Abstract][Full Text] [Related]
29. Relative-assessed psychological factors predict sedation requirement in critically ill patients.
Green T; Gidron Y; Friger M; Almog Y
Psychosom Med; 2005; 67(2):295-300. PubMed ID: 15784797
[TBL] [Abstract][Full Text] [Related]
30. Nurse-administered propofol versus midazolam and meperidine for upper endoscopy in cirrhotic patients.
Weston BR; Chadalawada V; Chalasani N; Kwo P; Overley CA; Symms M; Strahl E; Rex DK
Am J Gastroenterol; 2003 Nov; 98(11):2440-7. PubMed ID: 14638346
[TBL] [Abstract][Full Text] [Related]
31. Age effect on efficacy and side effects of two sedation and analgesia protocols on patients going through cardioversion: a randomized clinical trial.
Parlak M; Parlak I; Erdur B; Ergin A; Sagiroglu E
Acad Emerg Med; 2006 May; 13(5):493-9. PubMed ID: 16569746
[TBL] [Abstract][Full Text] [Related]
32. The correlation between bispectral index and observational sedation scale in volunteers sedated with dexmedetomidine and propofol.
Kasuya Y; Govinda R; Rauch S; Mascha EJ; Sessler DI; Turan A
Anesth Analg; 2009 Dec; 109(6):1811-5. PubMed ID: 19923507
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the effect of protocol-directed sedation with propofol vs. midazolam by nurses in intensive care: efficacy, haemodynamic stability and patient satisfaction.
Huey-Ling L; Chun-Che S; Jen-Jen T; Shau-Ting L; Hsing-I C
J Clin Nurs; 2008 Jun; 17(11):1510-7. PubMed ID: 18482144
[TBL] [Abstract][Full Text] [Related]
34. Population pharmacokinetics of a propofol bolus administered in patients with major burns.
Yamashita S; Kaneda K; Han TH
Burns; 2010 Dec; 36(8):1215-21. PubMed ID: 20510522
[TBL] [Abstract][Full Text] [Related]
35. [Analgo-sedation in intensive care: a quantitative, EEG-based trial with propofol 1% and 2%].
Albrecht S; Ihmsen H; Suchodolski K; Frenkel C; Schüttler J
Anaesthesist; 1999 Nov; 48(11):794-801. PubMed ID: 10631438
[TBL] [Abstract][Full Text] [Related]
36. [Population pharmacokinetic modeling and evaluation of propofol from multiple centers].
Ye HB; Zheng H; Zhang XA; Chi XJ; Chen WY; Xu JG; Li JH; Rui JZ
Yao Xue Xue Bao; 2010 Dec; 45(12):1550-8. PubMed ID: 21351496
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma.
Joerger M; Huitema AD; Meenhorst PL; Schellens JH; Beijnen JH
Cancer Chemother Pharmacol; 2005 May; 55(5):488-96. PubMed ID: 15726371
[TBL] [Abstract][Full Text] [Related]
38. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
Zhou H; Mayer PR; Wajdula J; Fatenejad S
J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641
[TBL] [Abstract][Full Text] [Related]
39. Tolerance to propofol's sedative effect in mechanically ventilated Rabbits.
Ypsilantis P; Mikroulis D; Politou M; Tsoukali H; Pitiakoudis M; Didilis V; Theodoridis G; Bougioukas G; Simopoulos C
Anesth Analg; 2006 Aug; 103(2):359-65, table of contents. PubMed ID: 16861417
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics and pharmacodynamics of propofol/alfentanil infusions for sedation in ICU patients.
Frenkel C; Schuttler J; Ihmsen H; Heye H; Rommelsheim K
Intensive Care Med; 1995 Dec; 21(12):981-8. PubMed ID: 8750122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
